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Introduction
Actinomycosis is the name given to an infection caused
by the genus, Actinomyces, a group of anaerobic Gram-
positive bacilli, which can be found in the normal mi-
croflora of the oral cavity, pharynx, gastrointestinal (GI)
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SUMMARY
Objective: Actinomycosis with an extended pelvic abscess is an uncommon condition, which usually occurs coin-
cident with the presence of an intrauterine contraceptive device (IUD) in the uterine cavity. The clinical picture
of pelvic actinomycosis may vary between individuals, is often accompanied by complications, and is frequently
misdiagnosed. Here, we report a case of pelvic actinomycosis, presenting as a huge pelvic mass and compli-
cated by a vaginal fistula, a cutaneous fistula, and bilateral hydronephrosis, and we discuss the diagnosis and
management of this patient.
Case Report: A 35-year-old woman was referred to our hospital with a huge pelvic complex mass and progres-
sively worsening low abdominal pain. The tumor workup, which included a computed tomography (CT) scan,
revealed an extended pelvic abscess and bilateral hydronephrosis. Both cutaneous and vaginal fistulas were also
noted. Endometrial curettage and biopsies of the skin and vaginal lesions confirmed the diagnosis of actinomy-
cosis. The patient underwent conservative treatment and recovered well, although the skin lesion only healed
after 12 weeks of oral antibiotic treatment. At the 1-year follow-up, a CT scan showed sequelae including a mildly
atrophic left kidney and left hydronephrosis.
Conclusion: In patients presenting with a pelvic mass and an IUD in the uterine cavity, the diagnosis of actino-
mycosis should be seriously considered. A detailed workup, including a CT scan, endometrial curettage and
biopsies where possible, should be performed before surgery. Once diagnosis has been confirmed, conservative
medical treatment should be attempted before considering laparotomy, to reduce the risk of complications.
Despite successful treatment with antibiotics, long-term sequelae such as hydronephrosis and renal atrophy are
possible in cases of extended pelvic actinomycosis. [Taiwan J Obstet Gynecol 2008;47(2):206–211]
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tract and genital organs in humans [1]. Actinomycotic
infections usually present as localized, chronic, infiltra-
tive granulomatous tumors of the cervicofacial region,
oral cavity, respiratory system (including the bronchi),
and GI system (including the liver) [2–5]. However,
they are also known to cause extensive infiltrative infec-
tions, such as endometritis, tubo-ovarian abscesses or
abdominal abscess, in women who have used long-
standing intrauterine contraceptive devices (IUDs). The
relationship between IUDs and pelvic actinomycosis
has been established since the 1970s [6–9], and such
IUD-associated infections can be sufficiently extensive
to cause severe pelvic adhesions, GI obstruction, fistula
formation, and hydronephrosis. However, the presen-
tation of an infiltrative pelvic abscess, complicated by
bilateral hydronephrosis and vaginal and cutaneous
fistulas, has rarely been reported. Here, we report a case
of a huge pelvic actinomycotic abscess with the above
clinical presentation, which showed a good response
to conservative antibiotic treatment. To the best of our
knowledge, this is the first reported case of an individual
with pelvic actinomycosis, with simultaneous cutaneous
and vaginal fistulas and bilateral hydronephrosis, with-
out bowel injury.
Case Report
A 35-year-old woman was referred to the emergency unit
of our hospital from local clinics because of a 2-week
history of progressively worsening low abdominal pain
and vaginal bleeding. On arrival, she was noted to have a
low grade fever (37.3°C) but otherwise stable vital signs.
Pelvic examination showed an enlarged uterus with the
vaginal cavity filled with a suppurative bloody discharge.
A small pit was noted in the posterior fornix of the vagina,
suggesting fistula formation (Figure 1). Physical exam-
ination also revealed an infiltrative erythematous area
(about 8 × 10 cm) at the left lower abdominal wall, with
no signs of peritonitis or GI obstruction. There were
several perforation holes on the surface of the skin lesion
(Figures 2–4). Ultrasonography revealed an infiltrating
complex pelvic mass with no obvious margin, and an
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Figure 1. (A) Direct view of external os and vagina. (B) The arrows indicate the external os and the fistula tract of the vagina.
Ext. OS = external os; Susp. fistula = suspected fistula.
Figure 2. Skin lesion at left lower abdomen.
Figure 3. Skin lesion of left lower abdomen showing typical
signs of infection.
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IUD in the uterine cavity. On arrival, the laboratory
data for this patient showed mild anemia (hemoglobin
7.9 g/dL), mild leukocytosis (white blood cell count
12,700/µL) without urinary tract infection, elevated
C-reactive protein (15.1 mg/dL), and otherwise normal
serum biochemistry. The serum CA125 level was also
within normal limits (24.62 U/mL). Some granulation
tissue protruding through the vaginal fistula was taken
for pathologic examination.
Due to a suspected pelvic mass with suspicious
abscess formation and abdominal wall and vaginal inva-
sion, the patient was admitted for detailed workup.
She underwent a computed tomography (CT) scan,
which unexpectedly revealed marked bilateral hydrone-
phrosis and hydroureter (Figures 5 and 6), as well as an
ill-defined heterogeneous infiltrative mass with cystic
and soft tissue parts occupying the cul-de-sac, both
sides of the perirectal fascia, both sides of the para-
metrium, and the left side of the retroperitoneum. The
lesion was also noted to invade the right psoas and
iliopsoas muscles and to extend to the left abdominal
wall, through a fistula tract (Figures 7 and 8).
The in situ IUD and extensive pelvic mass suggested the
possibility of pelvic actinomycosis. Surgical interventions,
Figure 4. There are two perforation holes, indicating cuta-
neous fistula formation.
Figure 6. Computed tomography scan with contrast. The
arrows indicate the hydroureter.
Figure 7. Computed tomography scan. The arrows indicate
the fistula tract towards the left lower abdominal wall.
Figure 8. Computed tomography scan. The arrows indicate
the skin lesion at the left lower abdominal wall.
Figure 5. Computed tomography scan with contrast. The
arrows indicate bilateral hydronephrosis.
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including an exploratory laparotomy, were not under-
taken, and instead, diagnostic endometrial curettage,
cutaneous lesion biopsy, and ultrasound-guided pelvic
mass biopsy were performed. The IUD was also removed
during the operation. Pathology reports confirmed the
diagnosis of actinomycotic infiltration and were neg-
ative for malignancy. Microbiologic cultures from the
abdominal and vaginal fistula tracts produced negative
results.
The patient underwent conservative treatment with
parenteral antibiotics. She was given aqueous penicillin
10 million IU every 6 hours, which was changed to
Augmentin 1 g orally every 12 hours after 3 days. The
fever subsided following antibiotic treatment. The ab-
dominal wall lesion shrank progressively but did not heal
until week 12 of oral antibiotic treatment. This patient
underwent follow-up ultrasonography after 3 months
of oral antibiotics. At this time, the right-sided pelvic
abscess was reduced and the left-sided pelvic mass had
shrunk to half its original size. Oral antibiotic treatment
was continued for a further 3 months, until there was no
detectable residual left pelvic infiltrating mass. Because
of personal reasons, the follow-up CT scan was delayed
until 1 year after the primary treatment, at which time
it showed mild left kidney atrophy with reduced con-
trast enhancement (Figures 9 and 10). The left kidney
measured 7.31×3.91 cm. A detailed anatomic and func-
tional work-up of the left kidney was advised but was
refused by the patient because of personal reasons (she
was an immigrant).
Discussion
Actinomycosis is often considered to be an opportunis-
tic infection that manifests itself in the cervicofacial
(50%), abdominal (20%) and thoracic (15%) areas. Pelvic
actinomycotic abscesses are known to be related to the
long-term use of an IUD [6,9]. Actinomyces colonies are
usually present in the removed IUD, though the pres-
ence of Actinomyces in the genital organs or an IUD does
not necessarily indicate an infective disorder. The esti-
mated prevalence of actinomycosis is low [1], even in
HIV-positive patients [10]. However, IUD-related pelvic
actinomycotic abscesses are often reported. Some pelvic
actinomycoses appear as wide-spreading and extensive
infiltrating abscesses. GI tract involvements, including
GI obstruction [11], bowel fistula formation, bleeding
and extensive adhesions, are the most common com-
plications [12,13]. Other reported complications of
pelvic actinomycosis include abdominal wall abscesses
and fistula formation [14], vaginal involvement, and
unilateral or bilateral hydronephrosis [15–17]. Such
complications have rarely been recorded simulta-
neously. We believe this patient to be the first reported
case of primary pelvic actinomycosis presenting simulta-
neously as abdominal and vaginal fistulas, and bilateral
hydronephrosis.
The preoperative diagnosis of actinomycosis can be
very difficult. Most pelvic masses are treated as suspected
ovarian tumors, and thus receive surgical interventions,
with the diagnosis being confirmed postoperatively,
based on the pathologic findings [1,11]. In our case, the
pelvic mass also presented initially as a huge pelvic tumor
and surgical intervention was therefore considered. The
differential diagnosis of actinomycotic abscesses and
pelvic tumors, such as ovarian cancer, is often diffi-
cult; they show similar infiltrative and solid or complex
components on ultrasound and rarely cause marked
signs of infection, such as high fever, leukocytosis, pus
formation or sepsis. Exploratory laparotomy is com-
monly conducted but can lead to massive bleeding
Figure 9. Computed tomography scan at 1-year follow-up.
Note the enhancement difference between the bilateral kidneys.
Figure 10. Computed tomography scan at 1-year follow-up,
showing mildly dilated left renal pelvis.
and severe complications, requiring GI resection or
repair [18].
In our patient, the preoperative diagnosis of acti-
nomycosis was confirmed by ultrasound-guided biopsy,
abdominal wall biopsy, and biopsy of the vaginal fistula.
Fistula formation in both the vagina and abdominal
wall was helpful in establishing the correct diagnosis in
this patient. In most cases of ovarian or pelvic tumors,
preoperative needle biopsy is not recommended because
of the possibility of tumor dissemination, but this policy
also restricts the opportunity to confirm the actinomy-
cotic infection preoperatively, and so avoid unneces-
sary complications. However, in our case, tissue could
be obtained from the two fistula tracts, thus allowing
an early diagnosis. Furthermore, ultrasound-guided nee-
dle biopsy of the pelvic mass excluded the possibility 
of malignancy. We therefore administered antibiotic
treatment with a good clinical response. If the tumor
size, hydronephrosis and infective signs fail to respond
well to medication, surgical intervention should still be
considered.
The important role of CT scans in confirming the
diagnosis of pelvic actinomycotic abscesses has been
demonstrated [19,20]. In our case, the primary physical
examination revealed no costophrenic angle knocking
pain, and there were no symptoms, signs or complaints
concerning the urinary tract, such that CT scanning was
required to identify the severe bilateral hydronephro-
sis. The CT scan also helped to visualize the spreading
tract of the abscess, and thus helped to confirm the
consistency and accuracy of the biopsy results. In some
cases, if an ultrasound-guided biopsy is not achievable,
a CT-guided biopsy may be considered [21].
In this case, we conducted diagnostic endometrial
curettage and removal of the IUD to confirm the diag-
nosis and exclude the possibility of malignancy. The
pathology report confirmed the presence of Actinomyces
in the uterine cavity. However, as the “original” site of
Actinomyces colonization, the uterine cavity showed much
less inflammation than the other spreading lesions.
Extensive pelvic abscesses without signs of endometritis
may sometimes delay an accurate diagnosis, and this
should be kept in mind.
The recommended primary management of actino-
mycosis is antibiotic treatment. Penicillin G 20 million
IU/day parenterally is advised. However, because there
was some pus coating on the abdominal lesion, we also
administered metronidazole and gentamicin to avoid
secondary infection. After primary parenteral antibi-
otics, Augmentin treatment was continued because of
its broad spectrum. There have been at least two reports
in the literature of cases of pelvic actinomycoses that
recurred weeks [22] or even months [23] after removal
of the IUD, and regular image follow-up is therefore
strongly recommended.
This patient had severe bilateral hydronephrosis but
normal serum renal function tests. We consulted the
urologist concerning management of the hydronephrosis;
primary double-J tube insertion was not recommended
because of possible complications, such as perforation.
The hydronephrosis improved after conservative treat-
ment, but the 12-week follow-up ultrasound and 1-year
follow-up CT scan still showed signs of left hydronephro-
sis. Mild left renal atrophy and left hydronephrosis were
confirmed as long-term sequelae. Early double-J tube
insertion may be helpful in preventing such long-term
sequelae, but may also lead to severe complications such
as renal loss. There is no single recommended treatment
for patients with pelvic actinomycosis and hydronephro-
sis. Renal failure has been reported [24], and the man-
agement of primary hydronephrosis with the aim of
preventing long-term sequelae, as well as the optimal
timing of interventions, still presents a significant chal-
lenge in the treatment of such cases. Serial follow-up
and careful consideration of individual cases are strongly
recommended.
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